Researchers conducted clinical studies on murine animals and humans to evaluate the impact of high protein intake on the amino acid-mammalian target of the rapamycin complex 1 autophagy signaling pathway.
Esteve to acquire Perrigo’s rare disease pharma business for up to $295M
Perrigo announced Thursday that Barcelona-based pharma company Esteve Healthcare has agreed to purchase its three rare disease drug assets for as much as €275 million